Ameriprise’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.45M Sell
110,986
-194,208
-64% -$10.5M ﹤0.01% 2267
2025
Q4
$14.1M Sell
305,194
-69,708
-19% -$3.12M ﹤0.01% 1663
2025
Q3
$13.5M Buy
374,902
+44,231
+13% +$1.47M ﹤0.01% 1683
2025
Q2
$10.8M Sell
330,671
-347,910
-51% -$11.4M ﹤0.01% 1762
2025
Q1
$25.6M Sell
678,581
-38,192
-5% -$3.05M 0.01% 1169
2024
Q4
$58.7M Buy
716,773
+366,622
+105% +$36.4M 0.02% 758
2024
Q3
$40M Buy
350,151
+72,387
+26% +$6.52M 0.01% 946
2024
Q2
$21M Buy
277,764
+159,231
+134% +$10.8M 0.01% 1252
2024
Q1
$8.1M Buy
118,533
+76,008
+179% +$5.26M ﹤0.01% 1984
2023
Q4
$2.67M Buy
42,525
+30,846
+264% +$1.6M ﹤0.01% 2737
2023
Q3
$595K Buy
+11,679
New +$576K ﹤0.01% 3338

Other funds holding PCVX